Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Nature Neuroscience

Volumn 3, Issue 12, 2000, Pages 1301-1306

  Betarbet, R ^a   Sherer, T B ^a   MacKenzie, G ^a   Garcia Osuna, M ^a   Panov, A V ^a   Greenamyre, J T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PESTICIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HYPOKINESIA; MITOCHONDRION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; DOPAMINE; DYSKINESIAS; ELECTRON TRANSPORT COMPLEX I; ENVIRONMENTAL EXPOSURE; LEWY BODIES; MALE; NADH, NADPH OXIDOREDUCTASES; NEOSTRIATUM; NERVE DEGENERATION; NEURAL PATHWAYS; NEURONS; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PRESYNAPTIC TERMINALS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; ROTENONE; SUBSTANTIA NIGRA;

EID: 0033681149     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/81834     Document Type: Article

References (41)

1. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
2. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
3. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
4. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
5. Parkinson disease in twins: An etiologic study
6. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
7. Parkinson's disease, pesticides, and glutathione transferase polymorphisms
8. Environmental antecedents of young-onset Parkinson's disease
9. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
10. Chronic parkinsonism in humans due to a product of meridine-analog synthesis
11. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
12. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds
13. Experimental models of Parkinson's disease: Insights from many models
14. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
15. Mitochondrial function in Parkinson's disease
16. Mitochondrial complex I deficiency in Parkinson's disease
17. Mitochondrial oxidative-phosphorylation defects in Parkinson's disease
18. Brain, skeletal-muscle and platelet homogenate mitochondrial function in Parkinson's disease
19. Mitochondrial respiratory-chain activity in skeletal muscle from patients with Parkinsons disease
20. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy
21. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
22. Mitochondrial dysfunction in Parkinson's disease
23. Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusions bodies in the MPTP-treated squirrel monkey
24. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
25. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies
26. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not the substantia nigra
27. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion
28. 3H] Dihydrorotenone binding to NADH: Ubiquinone reductase (complex I) of the electron transport chain: An autoradiographic study
29. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria
30. Immunochemical analysis of dopamine transporter protein in Parkinson's disease
31. Dopamine (3-hydroxytyramine) and brain function
32. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration
33. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid
34. A modified histochemical technique to visualize acetylcholinesterase-containing axons
35. Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site
36. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors
37. Dityrosine cross-linking promotes formation of stable α-synuclein polymers
38. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease
39. Inhibitors of NADH-ubiquinone reductase: An overview
40. Substrate specific effects of calcium on metabolism of rat heart mitochondria
41. Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation